OrthoPediatrics Corp. , a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally.
Orthopediatrics stock last closed at $31.20, up 1.86% from the previous day, and has decreased 37.12% in one year. It has underperformed other stocks in the Medical Devices industry by 0.2 percentage points. Orthopediatrics stock is currently +35.06% from its 52-week low of $23.10, and -41.68% from its 52-week high of $53.50.
As of Apr 24, 2024, there are 23.55M KIDS shares outstanding. The market value of KIDS is $734.74M. In the past 24 hours, 83,481 KIDS shares were traded.
How to Buy Orthopediatrics Stock
Not sure how to invest in Orthopediatrics stock? Here's how.
Decide where to buy Orthopediatrics stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Orthopediatrics stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Put funds into your brokerage account: Pick your payment method and add your info.
Analyze Orthopediatrics stock: The Orthopediatrics ticker symbol is KIDS. Is Orthopediatrics stock a good investment? Should you buy shares of KIDS? How do KIDS's underlying business fundamentals look? Do top analysts think Orthopediatrics is a good buy? Why has KIDS's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if KIDS is a good stock to buy).
Make your KIDS buy order: Decide if you will purchase KIDS shares at the current market price or use a limit order to purchase KIDS stock at a specific price.
Get the latest news on your KIDS investment: Create a watchlist to keep tabs on your new investment in Orthopediatrics shares.
Step 1: Decide where to buy Orthopediatrics stock
You will need an online brokerage account to access the NASDAQ market and buy KIDS shares.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world markets: From Technology to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected your brokerage, you need to fill out some personal information so you can invest in KIDS stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 3: Put funds into your brokerage account
Now that you have filled out your info on one of the most highly reviewed stock market apps, your next step is to transfer the money for your investment:
Watch the tutorial below for more details transferring funds into your investment account.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Orthopediatrics stock
Once you have identified the best place to buy Orthopediatrics stock, it's absolutely critical to evaluate their stock prior to investing, so you actually understand the risk and upside.
Orthopediatrics stock quick numbers
KIDS Price
$31.20
1w %
4.35%
1y %
-37.12%
5y %
-18.07%
P/E
-33.91x
P/B
1.95x
P/S
4.76x
PEG
N/A
Revenue
$148.73M
Earnings
-$20.97M
Fore. Rev. Growth
26.25%
Fore. Earn. Growth
N/A
Market Cap
$734.74M
Next Earnings
May 7, 2024
Next Dividend
N/A
KIDS Overview
WallStreetZen was built to help average investors perform more accurate fundamental analysis quickly.
There are more short-term assets than long-term liabilities on the KIDS balance sheet.
KIDS has a low debt to equity ratio of 0.16.
There are more short-term assets than short-term liabilities on the KIDS balance sheet.
Total KIDS debt is lower than 5 years ago, relative to shareholder equity.
KIDS has cash burn of 43924000. It has sufficient cash and short-term investments to cover this for at least one year.
KIDS has $82.28M in cash and short term investments. This is enough to cover its annual cash burn of $43.92M.
Negative Health Checks:
KIDS profit margin has gone down from 1% to -14.1% in the past year.
Do analysts think it's a good time to buy Orthopediatrics stock
Out of 6 Equities analysts who research KIDS, the consensus analyst rating on KIDS is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent KIDS Analyst Recommendations
Richard Newitter, a top 6% analyst from Truist Securities maintains KIDS with a strong buy rating and raises their KIDS price target from $35.00 to $39.00, on Dec 22, 2023.
Truist Securities's Richard Newitter raised their price target on Orthopediatrics (NASDAQ: KIDS) by 11.4% from $35 to $39 on 2023/12/22. The analyst maintained their Strong Buy rating on the stock.
Newitter announced their price target move on Orthopediatrics in a research note covering MedTech names in their Healthcare (Medical Devices) portfolio.
The analyst told investors they "are turning more positive on the MedTech segment heading into FY 2024" on the basis of "dwindling recession fears, a downward interest rate bias/perception, a more pragmatic view toward the GLP1 overhang/impact, and an attractive overall segment growth profile for next year."
Acknowledging that FY 2023 was a "tough" year for Healthcare names, MedTech "could be a relatively safe destination for funds within the broader sector and even inter-sector as a beta/growth segment that underperformed," Newitter argued.
Last year, KIDS revenue was $148.73M. In the past five year, KIDS's revenue has grown by 20.91% per year. This was faster than the Medical Devices industry average of 13.35%.
No, Orthopediatrics doesn't provide an income stream by paying out dividends.
What others are saying about KIDS
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your KIDS buy order
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are mostly fine for most investors.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a given dollar amount limit, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you want additional help with investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Orthopediatrics share?
As of Apr 24, 2024, it costs $31.20 to buy one share of Orthopediatrics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.321 shares of KIDS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.